Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
This report contains market size and forecasts of Overactive Bladder Treatment in Global, including the following market information:
Global Overactive Bladder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Overactive Bladder Treatment market was valued at 5247.6 million in 2021 and is projected to reach US$ 6397.6 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Overactive Bladder Treatment include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic and KYORIN Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Overactive Bladder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Overactive Bladder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Overactive Bladder Treatment Market Segment Percentages, by Type, 2021 (%)
Drugs
Device
Global Overactive Bladder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Overactive Bladder Treatment Market Segment Percentages, by Application, 2021 (%)
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Global Overactive Bladder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Overactive Bladder Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Overactive Bladder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Overactive Bladder Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Medtronic
KYORIN Pharmaceutical

LEAVE A REPLY

Please enter your comment!
Please enter your name here